← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Candesartan cilexetil + idroclorotiazide currently has availability issues reported in 2 European registers: Austria, Italy.
Shortage ATC — · also listed as: HYDROCHLOROTHIAZID; CANDESARTAN CILEXETIL · CANDESARTAN CILEXETIL + IDROCLOROTIAZIDE · data refreshed 9 September 2026
As of 9 September 2026, 2 of the 9 tracked registers list current availability issues for Candesartan cilexetil + idroclorotiazide, covering 5 affected product presentations. The longest-running open report was filed in Italy on 2022-12-12 and has now been open for about 45 months. Where agencies state a cause, manufacturing problems lead with 2 of the 2 stated-cause reports. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Blopress Plus 32 mg/12,5 mg - Tabletten + 2 more productsBlopress Plus 32 mg/25 mg - Tabletten Candesartan/HCT 1A Pharma 8 mg/12,5 mg - Tabletten | 2025-11-27 | — | — | register ↗ |
| 🇮🇹 Italy | Shortage CANDESARTAN E IDROCLOROTIAZIDE MYLAN GENERICS + 1 more productsCANDESARTAN E IDROCLOROTIAZIDE ZENTIVA ITALIA | 2022-12-12 | — | Problemi produttivi Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Candesartan cilexetil + idroclorotiazide in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇦🇹 AT | Candesartan/HCT 1A Pharma 8 mg/12,5 mg - Tabletten | Shortage | 2026-07-27 | — | |
| 🇮🇹 IT | CANDESARTAN E IDROCLOROTIAZIDE MYLAN GENERICS | Shortage | 2026-05-15 | — | Problemi produttivi |
| 🇦🇹 AT | Blopress Plus 32 mg/12,5 mg - Tabletten | Shortage | 2025-11-27 | — | |
| 🇦🇹 AT | Blopress Plus 32 mg/25 mg - Tabletten | Shortage | 2025-11-27 | — | |
| 🇮🇹 IT | CANDESARTAN E IDROCLOROTIAZIDE ZENTIVA ITALIA | Shortage | 2022-12-12 | — | Problemi produttivi: forniture discontinue |
Yes. As of 9 September 2026, availability issues are reported in: Austria, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Candesartan cilexetil + idroclorotiazide: BASG (Austria), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Candesartan cilexetil + idroclorotiazide — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/candesartan-cilexetil-idroclorotiazide/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Candesartan cilexetil + idroclorotiazide availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/candesartan-cilexetil-idroclorotiazide/">Candesartan cilexetil + idroclorotiazide shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>